OTCPK:CVSC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Cardiovascular Sciences

Executive Summary

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has Cardiovascular Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CVSC's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

CVSC

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

9,900.0%

CVSC

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: CVSC exceeded the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: CVSC exceeded the US Market which returned 13.8% over the past year.


Shareholder returns

CVSCIndustryMarket
7 Day0%-1.7%-0.8%
30 Day900.0%-3.5%-5.7%
90 Dayn/a12.2%8.6%
1 Year9,900.0%9,900.0%17.5%16.5%16.4%13.8%
3 Yearn/a70.0%65.6%36.9%27.8%
5 Yearn/a139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is Cardiovascular Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Cardiovascular Sciences undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Cardiovascular Sciences is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Cardiovascular Sciences has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Cardiovascular Sciences's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Cardiovascular Sciences regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Cardiovascular Sciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cardiovascular Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Cardiovascular Sciences performed over the past 5 years?

15.4%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Cardiovascular Sciences has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Cardiovascular Sciences's financial position?


In this section we usually analyse Cardiovascular Sciences's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Cardiovascular Sciences has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of CVSC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Cardiovascular Sciences's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Cardiovascular Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CVSC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CVSC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CVSC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CVSC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CVSC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

15.7yrs

Average management tenure


CEO

Larry Hooper

no data

Tenure

Dr. Larry Hooper, M.D. serves as Chief Executive Officer of Cardiovascular Sciences, Inc. Dr. Hooper is a physician. He holds B.A. in Chemistry and Psychology from University of North Carolina at Chapel Hi ...


Leadership Team

NamePositionTenureCompensationOwnership
Byron Rambo
Chief Financial Officer17.67yrsno datano data
Michael D'Apolito
President of Weight Loss & Wellness17.17yrsno datano data
Larry Hooper
Chief Executive Officerno datano datano data
Tim Murray
President15.67yrsno datano data
Sandy Williams
Director of Operations14.5yrsno datano data
Brian Schneider
Executive Vice President14.58yrsno datano data

15.7yrs

Average Tenure

Experienced Management: CVSC's management team is seasoned and experienced (15.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Byron Rambo
Chief Financial Officer17.67yrsno datano data
Harold Kestenbaum
Director18.25yrsno datano data
John Martin
Director12.58yrsno datano data
Kenneth MacDonald
Director of Concorde Resources Corpno datano datano data

17.7yrs

Average Tenure

70yo

Average Age

Experienced Board: CVSC's board of directors are seasoned and experienced ( 17.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cardiovascular Sciences, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cardiovascular Sciences, Inc.
  • Ticker: CVSC
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$1.696k
  • Shares outstanding: 16.96m
  • Website: https://www.cvsciences.org

Location

  • Cardiovascular Sciences, Inc.
  • 3251 Progress Drive
  • Orlando
  • Florida
  • 32826
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CVSCOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 2001

Biography

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therap ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/28 04:27
End of Day Share Price2020/09/21 00:00
Earnings2009/03/31
Annual Earnings2008/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.